Lead academic: Dr Martin Nicklin
This flexible course focuses on the molecular and genetic factors of human diseases. Understanding those factors is crucial to the development of therapies.
Core modules cover the fundamentals. You choose specialist modules from the pathway that interests you most.
We also give you practical lab training to prepare you for your research project. The project is five months of invaluable laboratory experience: planning, carrying out, recording and reporting your own research.
Recent graduates work in academic research science, pharmaceuticals and the biotech industry.
You’ll be based in teaching hospitals that serve a population of over half a million people and refer a further two million. We also have close links with the University’s other health-related departments.
Our research funding comes from many sources including the NIHR, MRC, BBSRC, EPSRC, the Department of Health, EU, and prominent charities such as the Wellcome Trust, ARC, YCR, Cancer Research UK and BHF. Our partners and sponsors include Novartis, GlaxoSmithKline, Pfizer, Astra Zeneca and Eli Lilly.
You’ll also benefit from our collaboration with the Department of Biomedical Sciences.
Classes are kept small (15–20 students) to make sure you get the best possible experience in laboratories and in clinical settings.
We have a state-of-the-art biorepository and a £30m stem cell laboratory. The Sheffield Institute of Translational Neuroscience (SITraN) opened in November 2010. We also have microarray, genetics, histology, flow cytometry and high-throughput screening technology, and the latest equipment for bone and oncology research.
At our Clinical Research Facility, you’ll be able to conduct studies with adult patients and volunteers. The Sheffield Children’s Hospital houses a complementary facility for paediatric experimental medical research.
If your course involves a significant risk of exposure to human blood or other body fluids and tissue, you’ll need to complete a course of Hepatitis B immunisation before starting. We conform to national guidelines that are in place to protect patients, health care workers and students.
Genetic Mechanisms pathway
Microbes and Infection pathway
Experimental Medicine pathway
Clinical Applications pathway
Apply directly to this pathway. Available only to medical graduates. Students are recruited to a specialist clinical team and pursue the taught programme (1-5) related to the attachment. They are then attached to a clinical team for 20 weeks, either for a clinical research project or for clinical observations. See website for more detail and current attachments.
Lectures, seminars, tutorials, laboratory demonstrations, computer practicals and student presentations.
Assessment is continuous. Most modules are assessed by written assignments and coursework, although there are some written exams.
Two modules are assessed by verbal presentations.
Your research project is assessed by a thesis, possibly with a viva.
The MSc in Experimental Medicine offers advanced research training in a broad range of laboratory based biomedical sciences.
MSc in Experimental Medicine is designed for students wishing to pursue a career in experimental medicine, whether it is in academia, clinical practice, industry or government. The programme will also provide an excellent platform for progression to PhD programmes either in Queen’s or worldwide.
MSc in Experimental Medicine will develop a strong fundamental understanding of high quality biomedical research, including experimental design and execution, data management and interpretation, and scientific communication, including publishing, presentation, and use of social media.
The programme offers comprehensive research training with access to over 40 research groups and the state-of-the-art research facilities at the Centre for Experimental Medicine (CEM). Research facilities include Central Technology Units for Imaging and Genomics which are leading the way in research excellence and innovative healthcare.
Experimental medicine aims to identify mechanisms of pathophysiology of disease, and demonstrate proof-of-concept evidence of the efficacy and importance of new discoveries or treatments. There is an increasing need for graduates who can undertake basic and clinical research, and translate it into improved medical treatments for patients.
This research-intensive MSc programme in Experimental Medicine will equip you with the rigorous research skills, and the innovative mentality to tackle the major medical and therapeutic challenges of the 21st century.
The strong links between the Centre for Experimental Medicine and the biotech or biopharmaceutical sectors provides a stimulating experimental and translational environment, while also expanding your career opportunities.
WORLD CLASS FACILITIES
It comprises 3 months of intensive teaching, which includes essential research skills followed by specialist chosen modules entitled “Infection & Immunity”, or “Diabetes and Cardiovascular Disease”. The remaining period will provide a unique opportunity to focus for 8 months on an extensive research project chosen from a large panel of projects offered by Principal Investigators in the CEM in one of the above themes. This period will be interspersed with monthly training to develop project-specific transferable skills, such as oral and poster presentation, and scientific writing.Semester 2
You will specialise in one of these two research streams:
You’ll undertake a project at the Centre of Experimental Medicine, QUB, relating to the research stream that you have chosen.
Based on the indicative curriculum of Health Education England, NHS England and Genomics England LTD, the MSc in Genomic Medicine will equip research scientists and Health Care Professionals with; knowledge and skills to understand and interpret genomic data, an understanding of genetic and genomic techniques in a clinical setting, bioinformatic approaches required for analysis of genomic data, advanced knowledge and skills, preparing graduates to develop and deliver personalised health care.
MSc in Genomic Medicine students will be introduced to:
Subsequent study will build on these foundations. Specific modules on the MSc in Genomic Medicine focus on:
The Genomic Medicine course is primarily informed by the design developed to equip graduates, and a diverse range of healthcare professionals, with an appreciation and education in genomics and genomic technology. As an emerging field of expertise this knowledge and understanding of genomics will prepare Genomic Medicine graduates to translate their newfound knowledge of genomics into the clinical setting to inform patient care.
The MSc in Genomic Medicine has been developed in line with Health Education England, NHS England and Genomics England Ltd.
Genomic Medicine students will be introduced to the fundamentals of human genetics and genomics along with techniques required for DNA and RNA sequencing to study genomic variation observed in the clinical setting. A third module entitled Data Analysis for Health and Medical Sciences, will introduce the bioinformatic approaches required for the analysis of genomic data.
Students will learn and be taught through a variety of methods including: lectures, workshops, tutorials, practical sessions, work-based learning and guest lectures by professionals, practitioners and respected academics.
Employability is key to the Genomic Medicine programme. Our students will be able to enhance their employability skills through their education and training in genomic medicine, transforming both the specialist and general workforce within the NHS. Furthermore, for non-NHS funded students, the MSc in Genomic Medicine will prepare graduates for careers in the clinical setting for which a knowledge of genomics will improve service delivery to patients.
The masters’ element of this programme will require students to complete a Research Project or in depth literature review. Genomic Medicine students will be encouraged to undertake their research project within the NHS, either within the students hosting NHS department or where they may expect to work following graduation.
Please note: fees of accepted, eligible NHS-based applicants will be paid by the Workforce Education and Development Services (WEDS).
Workforce Education and Development Services (WEDS) funding: WEDS is offering to pay the tuition fees for eligible staff working for the NHS in Wales, to study for the MSc, PG Dip or PG Cert in Genomic Medicine (part-time only).
Our flexible, blended MSc Molecular Pathology course will enable you to take advantage of growing opportunities within this field, which is critically important for translational medicine, both in cancer and non-cancer diseases.
The number of academic pathologists trained in molecular pathology has steadily declined over the past 20 years. As such, it has been identified as an area requiring support and development by the Medical Research Council (MRC) and the Royal College of Pathologists, creating careers opportunities for students and professionals alike.
Our master's course is aimed at medical students, biomedical scientists, medical practitioners and trainee pathologists who want to learn more about molecular pathology. Trainee pathologists can take our course as part of an existing training programme.
You will benefit from a unique focus on the molecular analysis of tissue samples and take optional units in various areas of laboratory medicine and emerging diagnostic methods, such as proteomics and chemical pathology.
Students will also become part of Manchester's world leading precision medicine research community, learning practical skills that will be directly applicable to this emerging field.
In addition, you will benefit from our association with the network of MRC and Engineering and Physical Sciences Research Council funded Molecular Pathology nodes, which have been partly established to train more scientists to work in this field. This will enable you to connect with colleagues and related opportunities across the UK.
This course aims to provide you with a wide and detailed understanding of the various aspects of molecular pathology.
Provided as part of The University of Manchester MRC/EPSRC Molecular Pathology node (Manchester Molecular Pathology Innovation Centre), we recognise the need for providing more training in molecular pathology among histopathology trainees, clinical scientists and biomedical scientists.
As such, the course addresses a wide audience, and has a broad range of both core and non-core course units to facilitate the different learning and training needs of different groups of professionals.
In addition to the taught components, which will give an in-depth understanding of molecular pathology and associated disciplines (including genomics and bioinformatics), the full MSc course will also develop your experience of and skills in scientific investigation, analytical thought and scientific criticism.
Professional input into course content
This course has been designed to take into consideration the training requirements of biomedical scientists, clinical scientists and medical histopathologists. We have consulted with local Postgraduate Deaneries and associated professional bodies including the Institute of Biomedical Scientists (IBMS) and the Royal College of Pathologists to tailor the content.
The option to take the course over four years will particularly appeal to specialist trainee pathologists, who will be able to fit study around their clinical training. They can also use Year 4 to undertake the research project over three months on a full-time, salaried basis, as per RCPath regulations and Deanery funding.
Teaching is largely delivered through face-to-face, interactive sessions, consisting of some lecture material, with discussions and group work, and with a range of audio-visual stimuli including PowerPoint slides, images and videos.
All units are supported by the use of Blackboard (a virtual learning environment) on which staff post lecture slides, reading lists and other accompanying material.
Each unit on Blackboard also has its own discussion board, where you can interact with staff and other students on the course, for example, by posting and responding to questions, and making comments related to the course.
For students completing the full MSc, a significant amount of teaching and learning will take place through the dissertation research unit (60 credits or 30 credits), in which you will be expected to take a lead role in developing a research project with regular support, input, and mentorship from your project supervisor.
Formative assessments will be given throughout the taught component of the course and will take the form of MCQs, short answer questions, verbal presentations, data and method analysis exercises.
A range of summative assessments will be employed to assess your knowledge and understanding, and the development of your intellectual and transferable skills including:
The assessment methods employed by each unit will vary and will be tailored to match the material delivered and stated ILOs of that particular unit.
Your ability to gather information from a wide range of sources, evaluate and critically analyse information, make considered judgments about that information and synthesise material into logical and coherent pieces of work will all be assessed.
Examples of the marking proformas used in the assessment of verbal and written assignments will be provided in student handbooks and on Blackboard, the University's virtual learning environment.
As per the postgraduate taught degree regulations, students exiting with a postgraduate diploma (or postgraduate certificate) may be permitted to rescind this award and upgrade to a master's (or postgraduate diploma) by successfully completing the appropriate further component of the course, providing the following conditions are met:
Course content for Year 1
Optional units (max 1 per semester):
Course content for Year 2
Optional units (max 1 per semester):
Aspiring to contribute to the development of new therapies for metabolic, infectious and immunological diseases or cancer? Radboud University's internationally acclaimed Research Master's programme in Molecular Mechanisms of Disease provides an excellent foundation for a career in academic or commercial research.
Only by dissecting the molecular mechanisms that trigger and advance diseases and dysfunctions can we design effective treatments and medicines. The Research Master's in Molecular Mechanisms of Disease (MMD) offers you an intensive two-year programme that provides you with in-depth knowledge and research experience of disease-related molecular mechanisms. In addition, you will acquire skills such as academic writing and presentation skills and learn how to successfully apply for grants and market yourself.
As an MMD student you will be part of the unique research community that is found within the Radboud Institute for Molecular Life Sciences (RIMLS). Like you, RIMLS researchers have a strong passion for research. They will assist you throughout the programme with guidance and expertise, supporting you in acquiring knowledge and developing excellent research skills. The RIMLS is one of the research institutes of the Radboud university medical center, so their research is closely linked to the clinic and thus aimed at translating results into treatments for patients. Examples include the translation of insights into the biology of antigen-presenting cells into new immunological cancer therapies and understanding the mutations underlying blindness into the development of gene therapies for patients with inherited blindness.
See the website http://www.ru.nl/masters/mmd
- You will follow a broad biomedical programme that allows you to specialise in your specific field-of-interest.
- You will have intense daily contact with established researchers.
- You will participate in group-oriented education and be part of a small group of highly motivated national and international students.
- A personal mentor will help you to reflect on your study programme and career perspective.
- You will do two 6-months research internships one of which will be abroad.
- There is a 92% pass rate of MMD students within the two years.
- International MMD students can apply for scholarships from the Radboudumc Study Fund.
There is considerable demand for experts in the molecular biomedical sciences as well as in their application to the development of treatments for diseases such as cancer, autoimmune and inflammatory disorders, and metabolic diseases.
Graduates in MMD are equipped with cutting-edge knowledge of multidisciplinary research in the mechanisms of disease and in state-of-the-art diagnostic methods and technologies. During the programme, you will develop a highly critical, independent approach to problem-solving. You will also acquire the basic management skills needed to lead R&D projects in the biotechnology and pharmaceutical industries.
Most of our graduates will enter an international PhD programme to continue with research in academia or industry.
The MSc Molecular Mechanisms of Disease aims to provide all skills and knowledge necessary to rapidly enter an international PhD programme. In the Netherlands and many places in Europe, it is impossible to start a PhD programme directly after obtaining a Bachelor's degree. This research Master’s programme seriously increases your chances for obtaining an excellent PhD training position by giving you a mature perspective and a broad range of experimental approaches. In fact, over 90% of our graduates has started a (funded) PhD project.
The Radboud Institute for Molecular Life Sciences (RIMLS) recruits about fifty PhD students a year. MMD graduates are excellent candidates for these positions. Furthermore, the Radboud university medical centre offers the opportunity for its research-oriented Master's students to write their own research project. The best candidates are awarded a fully funded four-year PhD studentship at the department of their choice.
The molecular regulation of cellular processes is crucial for human development, and maintenance of health throughout life. It's evident that cellular malfunction is the cause of common multi-factorial diseases such as diabetes, immune and inflammatory disorders, renal disease, cardiovascular, metabolic and neurodegenerative diseases as well as obesity and cancer.
The Radboud Institute for Molecular Life Sciences (RIMLS) Graduate School plays a key role in developing new therapies for the fight against such diseases. RIMLS aims to improve diagnostics and develop new treatments by generating basic knowledge in the molecular biomedical life sciences and translating it into clinical application and experimental research in patients.
The RIMLS – which is part of Radboud university medical center – offers an exclusive Master's programme in Molecular Mechanisms of Disease. Top researchers and clinicians teach the programme.
The MMD programme is organised along three major educational themes which reflect the main research areas present in the RIMLS and which each include both a fundamental and a disease-related aspect:
- Theme 1 Infection, Immunity and Regenerative Medicine / Immunity-related Disorders and Immunotherapy
- Theme 2 Metabolism, Transport and Motion / Metabolic Disorders
- Theme 3 Cell Growth and Differentiation / Developmental Disorders and Malignancies
See the website http://www.ru.nl/masters/mmd
Are you interested in the ever more revolutionary innovations in health and disease treatments, the potential to innovate, research new ways to treat diseases, set up a spin out company as a result of what you find, or work for top names in the industry?
If you want to study course modules within a variety of biotechnology, genetics, immunology, pharmacology, and microbiology areas but you want to choose the modules based on your aspirations this programme will not only give you choice of course modules but also great potential in many high growth and new generation revolutionary areas related to health and medical sciences and applications at the end of the programme.
We are living in an age of technological advances which are catapulting many fields including the health sciences into new ways to research and treat disease and new ways to produce and manufacture drugs and treatments. Biotechnology and pharmacy are enjoying a revolution in which customised health options, diagnosis, smart technologies, rapid prototyping and delivery, genomic sequencing, and molecular medicine are now possible and delivering new benefits to patients and economies. You study the essential areas of molecular medicine but you can choose from wide ranging courses such as Molecular Pharmacology, Drug Metabolism and Toxicology, Biologic Drug Discovery to Host-Pathogen Interactions and much more.
At the end of the programme you can choose your direction which can be anything from research science in private industry, institutes and centres, universities working towards PhD to finding a new method of treatment, rapid upscaling and spin out company possibilities. You may like to view the Scottish Innovation Centres within the health sciences to fully appreciate just how far you can take your expertise after graduation in Scotland and find out about innovation centres in England, Wales, Ireland or internationally.
International Student Fees 2017/2018
Find out about fees
*Please be advised that some programmes have different tuition fees from those listed above and that some programmes also have additional costs.
View all funding options on our funding database via the programme page
Find out more about:
Find out more about living in Aberdeen and living costs